Pharmsynthez Statistics

Total Valuation

Pharmsynthez has a market cap or net worth of RUB 1.36 billion. The enterprise value is 2.05 billion.

Market Cap	1.36B
Enterprise Value	2.05B

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmsynthez has 301.01 million shares outstanding. The number of shares has increased by 46.31% in one year.

Current Share Class	301.01M
Shares Outstanding	301.01M
Shares Change (YoY)	+46.31%
Shares Change (QoQ)	-9.97%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	25.00%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.70
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.33

Current Ratio	0.33
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.60% in the last 52 weeks. The beta is 0.04, so Pharmsynthez's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-24.60%
50-Day Moving Average	3.92
200-Day Moving Average	5.11
Relative Strength Index (RSI)	63.97
Average Volume (20 Days)	9,839,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 5.70 million in cash and n/a in debt, giving a net cash position of 5.70 million or 0.02 per share.

Cash & Cash Equivalents	5.70M
Total Debt	n/a
Net Cash	5.70M
Net Cash Per Share	0.02
Equity (Book Value)	1.95B
Book Value Per Share	4.42
Working Capital	-572.68M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharmsynthez does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.31%
Shareholder Yield	-46.31%
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1